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Surreptitious Ingestion of Oral Anticoagulants 
T h o m a s H . Greidanus, M . D . , * E l l i s J. V a n Slyck, M . D . , * * 
and R a y m o n d W . M o n t o , M . D . * * 
Hypoprothrombinemia secondary to surreptitious ingestion of coumarin or in-
danedione anticoagulants may be a difficult diagnosis for the unsuspecting physi-
cian. Four such case reports are presented. The disease should be suspected if the 
prothrombin time is markedly elevated and the individual is associated with the 
medical profession or has had previous treatment with oral anticoagulants. The 
diagnosis is confirmed by finding a deficiency in Factors II (prothrombin), VII, 
IX, and X and the presence of the coumarin or indanedione anticoagulant in the 
blood. The motive generally is that of gaining attention rather than committing 
suicide. Liver disease. Vitamin K deficiency states and accidental ingestion of oral 
anticoagulants are the chief disorders to be considered in the differential diagnosis. 
Specific assays for the oral anticoagulants are indicated before assuming a rarer 
etiology for the hemorrhagic syndrome. 
The oral anticoagulants, coumarin 
and indanedione derivatives, are com-
monly used for the treatment of throm-
boembolic disease. Since 1951, occa-
sional reports have appeared concern-
ing surreptitious ingestion of oral anti-
coagulants as a cause of hypoprothrom-
binemia.'Recent discussion on this 
subject by Bowie and associates^ and 
by O'Reilly and Aggeler-' has empha-
sized certain diagnostic features. In ad-
dition, they made the observation that 
this particular form of malingering gen-
erally occurs in individuals closely as-
sociated with the medical profession or 
who have had previous treatment with 
oral anticoagulants. 
Hypoprothrombinemia on the basis 
of surreptitious ingestion of coumarin 
or indanedione anticoagulants may pre-
sent a diflficult diagnostic and therapeu-
tic problem for the unsuspecting physi-
* Now in private practice in Edmonton, A l -
berta, Canada 
** Division of Hematology, Department of 
Medicine 
clan. Our purpose is to emphasize the 
characteristic features, the manage-
ment of the patient, the mechanism of 
competitive inhibition between oral 
anticoagulants and Vitamin K, and to 
discuss the psychodynamics of patient 
motivation. 
Materials and Methods 
Coagulation studies of four patients 
are presented in Table I . The prothrom-
bin time and plasma clotting time were 
measured by the methods described by 
Quick. The partial thromboplastin time 
was determined as described by Rod-
man, et al." Prothrombin consumption 
was performed as described by Suss-
man, et al,'^  the two-stage prothrombin 
assay by the method of Ware and See-
gers,* the thromboplastin generation 
test by the method of Biggs and Doug-
las,^  and the prothrombin and procon-
vertin test by the method of Owren and 
Aas.'" The concentration of warfarin 
in plasma was measured as described 
by O'Reilly, Aggeler and associates,'^  
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TABLE I 
CASE 1 CASE II CASE III CASE IV 
Bleeding time 
(in minutes) 4!4 
Lee-White clotting 
(time in minutes) 11^ & 14 14&19 m & 18^ m & 16^ 
Plasma clotting time 
(normal 80-12(1 sec.) 150 190 300 165 
Prothrombin time 
(in seconds) 
a) Control 
b) Patient 
12 
62 
15 
100 
15 
185 
12 
58 
Partial thromboplastin time (in seconds) 
a) Control 
b) Patient 
66 
over 560 
58 
no end pt. 
58 
270 
c) 1 part patient 
plasma plus 1 
part normal plasma 
65 100 
Prothrombin consumption 
(normal greater than 25 sec.) 145 93 95 42 
Two stage prothrombin assay (%of normal) 
a) Control 100 
b) Patient plasma with 
Factor V 7 
c) Patient plasma with-
out Factor V 7 
100 
13 
0 
100 
12 
100 
20 
19 
Factor II (%of normal) 6.5 0 12 19 
P & P test of Owren for 
Factor Vll & X(%of normal) 8.5 5 
Russell viper venom & cephalin 
test for Factor X (% of normal) 3 7 
Plasma Coumadin in mg./L. 9.8 8.1 
Coagulation studies in four cases of surreptitious ingestion of oral anticoagulants. 
and the concentration of bishydroxy-
coimiarin in plasma was measvured as 
described by Axelrod, Cooper and 
Brodie.12 
Case Reports 
Case I 
The patient, aged 60 years, a white house-
wife and school teacher, was referred for 
evaluation of abnormal bleeding and refrac-
tory hypoprothrombinemia. In September, 
1964, the patient developed thrombophlebitis 
following a fracture of the left leg. Sodium 
warfarin (Coumadin) therapy was initiated 
and continued until March, 1965. Recurrent 
thrombophlebitis necessitated reinstitution of 
warfarin in April, 1965. Subsequently, dur-
ing an episode of abdominal pain and hema-
turia, the prothrombin time was found to 
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be 19%. It returned toward the normal 
range following daily intravenous injections 
of phytonadione (Aquamephyton). Later, 
however, the prothrombin time was again 
found to be elevated, but failed to return to 
normal with daily oral and weekly intra-
venous Vitamin K. 
The patient was studied at a university 
hospital in another state. The only abnor-
malities found were a prothrombin time of 
10%, a clotting time of 28 minutes, and a 
sulfobromophthalein retention of 12.5% in 
45 minutes. The bleeding time was normal. 
An opinion was rendered that chronic liver 
disease accounted for her lowered prothrom-
bin levels. 
The patient continued to cause her family 
doctor serious concern. She appeared to re-
spond only to intravenous Vitamin K and 
accordingly received phytonadione 40 mgs 
once a week. Without this therapy, hema-
turia and ecchymoses would occur. The 
patient then developed local skin reactions 
at the sites of the Vitamin K injections and 
her physician feared an imminent systemic 
reaction of the anaphylactoid type. 
One year from the onset of her illness, she 
was admitted to the Henry Ford hospital on 
May 22, 1966. Her only medication at that 
time was 75 units of Lente insulin daily. She 
was a well-respected third grade school 
teacher, who had been seemingly happily 
married to a truant officer in the same school 
system for 37 years. 
On examination, the patient was a very 
pleasant, slightly obese, motherly type of 
woman who appeared younger than her age. 
A fading ecchymosis was noted on the but-
tocks. Physical examination was otherwise 
unremarkable. 
The routine laboratory examinations were 
normal, but the sulfobromophthalein test 
showed 9% retention in 45 minutes. The co-
agulation studies are recorded in Table I . 
There was a deficiency in Factors I I (pro-
thrombin), VII , X, and a probable deficiency 
in Factor IX (a test specifically for Factor 
IX was not performed). Significantly, the 
plasma warfarin level was found to be 9.8 
mg/litre. 
The diagnosis of coumarin toxicity was, 
therefore, established and her local physician 
was asked to contact her druggist. Her phy-
sician was surprised to find out that she had 
purchased refills of 5 mg warfarin tablets 
on at least five occasions during the previous 
year and as recently as two weeks before the 
present hospital admission. Consequently, 
her hospital room was searched in her ab-
sence, and warfarin 5 mgs was found 
wrapped in aluminum foil in her suitcase. 
These were left in place except for two tab-
lets taken as "evidence." 
On confrontation (by a psychiatrist), the 
patient denied self-medication, even though 
medicine had been found in her suitcase. 
However, several hours later, she stated to 
the medical resident, " I thought they were 
diet pills. I wasn't taking them intentionally." 
She then relinquished her supply of warfarin 
and vowed that she would never make the 
"mistake" again. The patient was permitted 
this face-saving explanation. 
The blood warfarin levels subsequently de-
creased at a rate consistent with normal in 
vivo degradation of the drug. Phytonadione 
was administered in a dose of 5 mg orally 
twice a day. Two days later her prothrombin 
time was 15 seconds. She returned to her 
community where she became free of hem-
orrhagic phenomena. 
Case II 
The patient was a 30-year-old, single 
white female who was a registered nurse. 
Nine years previously, while in training, she 
developed idiopathic thrombocytopenic pur-
pura. Symptoms were menorrhagia, metror-
rhagia and easy bruisability. She received 
three whole blood transfusions and was 
treated with corticosteroids for one year. 
Symptoms subsided except for a moderate 
degree of menorrhagia. 
In January, 1965, the patient sought medi-
cal attention for a recurrence of bruising 
and a worsening of menorrhagia. Between 
April and November, 1965, she was admitted 
to another hospital three times by her local 
physician. Her prothrombin time was as 
high as 102 seconds, but on each occasion 
the administration of intramuscular phy-
tonadione was followed by a return of the 
prothrombin time to normal within 24 hours. 
In late November, 1965, she was referred 
to Henry Ford Hospital for investigation of 
possible liver disease or malabsorption of 
Vitamin K. She had always been obese, 
weighing 250 pounds ten years previously 
and 290 pounds on admission. She had twice 
made half-hearted attempts to reduce, but 
stated that now she did not really care. 
On physical examination, in addition to 
marked obesity, several large ecchymoses 
were seen on the extremities and abdomen. 
The routine laboratory values and liver func-
tion profile were normal. However, the pro-
thrombin time was 54 seconds the night of 
admission, 103 seconds the following day 
and reached a peak of 227 seconds on the 
fourth day of hospitalization. During this 
time she was given oral phytonadione 5 mg 
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three times a day. Phytonadione 72 mg was 
then given intravenously. The prothrombin 
time was 134 seconds just prior to giving the 
intravenous Vitamin K, and did not change 
significantly over the following days. The 
coagulation studies are recorded in Table I . 
Direct determination of the presence of an 
oral anticoagulant in the blood or urine was 
not performed. 
The failure to observe a favorable re-
sponse of the prothrombin time to admin-
istered Vitamin K was interpreted as indirect 
evidence that the patient had taken a massive 
dose of a coumarin drug just before her 
admission to the hospital. It was also likely 
that she was continuing to consume the drug 
while under our observation. The patient 
hotly denied this on confrontation. Nonethe-
less, she was informed that she could keep 
from getting into difficulty by making cer-
tain that she avoided ingestion of this type 
of drug. Her cryptic reply was, "Well, that is 
easier said than done." Following discharge 
from the hospital she was admitted to an-
other hospital two months later with the 
same problem, and eventually underwent a 
hysterectomy. 
Case III 
The patient, aged 37 years, a single female 
housekeeper, was admitted July 23, 1958, 
with menorrhagia, melena, weakness, epi-
staxis, ecchymoses, and sore throat. She was 
acutely ill with marked pallor, a large hema-
toma in the pharynx, tender cervical and 
inguinal lymphadenopathy, diffuse abdominal 
tenderness and guarding, and ecchymoses 
confined mainly to the legs. The admission 
laboratory data included a hemoglobin of 
5.0 gm/100 ml and a platelet count of 175,-
000/ cu mm. The prothrombin time was 185 
seconds (control 15 seconds). Subsequent 
coagulation studies are shown in Table I . 
Interrogation of the elderly couple for 
whom the patient was a housekeeper, re-
vealed that the man was receiving phenpro-
coumon (Marcumar) for the treatment of 
arteriosclerotic heart disease. When asked to 
check his anticoagulant supply, he noted that 
much of his phenprocoumon was missing. 
Phytonadione 50 mg was given intravenously 
to the patient as well as several units of 
whole blood. Within 24 hours the prothrom-
bin time was 17 seconds (control 15 seconds). 
Subsequently, she admitted ingesting the 
anticoagulant. In this particular patient, this 
action was believed possibly to have repre-
sented an attempt to commit suicide. 
Case IV 
A white female student nurse, age 20 
years, was admitted to Henry Ford Hospital 
March, 1968, with hematuria. The hema-
turia began three months earlier and initially 
cleared after treatment with sulfamethoxa-
zole. Subsequently, the hematuria recurred 
and was associated with mild dysuria and 
frequency. Urine culture, excretory urogram, 
and cystoscopy were normal. Menstrual flow 
just prior to admission was unusually heavy. 
Because coagulation studies were suggestive 
of ingestion of oral anticoagulants, the 
patient was admitted to the hospital for fur-
ther clinical and psychiatric investigation. 
Her past history revealed symptomatology 
of recurrent "cystitis" since childhood. Her 
mother stated that her daughter always had 
a "weak bladder" and frequently sought 
medical care. Her local physician believed 
her symptomatology to be "functional" and 
warned against frequent medical contacts. 
Repeat urologic examinations over the years 
failed to reveal objective evidence to sup-
port her complaints except for two positive 
urine cultures which had been obtained 10 
months and 26 months prior to this admis-
sion. The patient was considered to be an ex-
cellent student nurse who was due to grad-
uate in three months. She was shy and rarely 
accepted dates. 
Physical examination was unremarkable 
except for several ecchymoses on the arms 
and legs. Laboratory studies were normal ex-
cept for a prothrombin time of 58 seconds. 
Coagulation studies are shown in Table I . 
The plasma warfarin level was 8.1 mg/litre. 
A search of the patient, her hospital room, 
and her nursing school quarters failed to re-
veal warfarin. When confronted with our 
knowledge of her warfarin ingestion, the 
patient initially denied this and failed to show 
any emotional response. Three days later the 
patient confessed to warfarin ingestion. After 
discharge from the hospital she was to be fol-
lowed by a psychiatrist with regard to emo-
tional factors. 
Discussion 
Hypoprothrombinemia is the result of 
a deficiency of one or more of those 
factors involved in the one-stage pro-
thrombin time. These are Factors I I 
(prothrombin), V, VII , and X. How-
ever Coumarin and the indanedione an-
ticoagulants depress Factors I I , VII , 
IX, and X and differ from one another 
only in their duration of action. Factor 
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V I I is depressed most rapidly, followed 
in 24 to 48 hours by depression of Fac-
tors I I , IX, and X. The action of these 
drugs occurs in the liver where they 
competitively interfere with Vitamin K 
synthesis, which thereby blocks the lat-
ter's contribution of a common protein 
precursor for the synthesis of Factors 
I I , V I I , IX, and X. In gross overdosage 
with coumarin, massive doses of Vita-
min K cannot restore the coagulation 
defect, suggesting that the relationship 
cannot be regarded as a simple com-
petitive system. 
Administration of Vitamin K doss 
not alter the rate of disappearance of 
coumarin from the blood stream, al-
though the prothrombin time may re-
turn to normal. This observation also 
emphasizes the competitive inhibition 
of coumarin by Vitamin K, the excess 
Vitamin K permitting normal synthesis 
of the deficient factors. Findings in our 
first case demonstrate this point. In 
Figure I , it is noted that two days fol-
lowing discontinuation of the warfarin 
(Coumadin), the plasma warfarin was 
at an elevated level, but the prothrom-
bin time was almost normal. When a 
patient has ingested a large amount of 
PROTHROMBIN 
TIME- SEC. e LOGO 
WARFARIN 
ZPM aA.M SAM. 
DAYS 
COUMADIN >IOmg q.d. t VITAMIN' 
1 10 mg qa. orally 
Figure 1 
Degradation curve for plasma warfarin dem-
onstrating practically normal prothrombin 
time on the seventh day while plasma war-
farin is still markedly elevated. 
oral anticoagulant, 50-100 mgs of 
Vitamin K intravenously daily for sev-
eral days is required to correct the pro-
thrombin time. The patient in our sec-
ond case was thought to have ingested 
such a large amount of an oral anti-
coagulant that 75 mgm of Vitamin K 
was not sufficient to influence the pro-
thrombin time. 
A related consideration requires em-
phasis. The coumarin and indanedione 
drugs, though measurably present in 
the plasma, are not circulating antico-
agulants since they exert theh activity 
only in the liver and have no eflect on 
coagulation in vitro. True circulating 
anticoagulants either block reactions 
between clotting factors (inhibitors) or 
destroy factors (inactivators). A screen-
ing test for circulating anticoagulants 
may be performed by adding one part 
normal plasma to one part patient's 
plasma and observing the effect on the 
plasma clotting time or partial throm-
boplastin time. If a circulating antico-
agulant is present, the coagulation de-
fect will persist. In our first two cases, 
the addition of normal plasma largely 
corrected the partial thromboplastin 
time, indicating that a true circulating 
anticoagulant was not present. 
Differential Diagnosis 
Congenital deficiency of Factors I I , 
V, V I I , or X are rare. Acquired hypo-
prothrombinemia occurs primarily as a 
result of (1) liver disease, (2) Vitamin 
K deficiency, or (3) ingestion of an oral 
anticoagulant. 
Parenchymal liver disease produces 
deficiences of the Vitamin K - depen-
dent clotting factors, but in addition, 
Factor V is often depressed. Sherlock 
et al^ ^ found that the extent of par-
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enchymal liver damage could be ade-
quately assessed by the prothrombin 
time, bUhubin, serum albumin, and 
the clinical picture. Pertinently, it was 
noted that their patients with known 
severe liver disease, who had a pro-
thrombin time of 1.5 times normal or 
longer, not correctable by parenteral 
Vitamin K therapy, died during that 
hospital stay. Therefore, a very long 
prothrombin time as an isolated finding 
will tend to eliminate parenchymal 
liver disease from the differential diag-
nosis. Furthermore, in parenchymal 
liver disease there is little or no re-
sponse to Vitamin K parenterally. A 
good response to parenteral Vitamin 
K is generally observed within 24hours 
in Vitamin K deficiency due to other 
causes. 
Dietary Vitamin K deficiency occurs 
as part of a complex of deficiencies in 
generalized malnutrition. Deficiency of 
Vitamin K also occurs when bile fails 
to reach the intestine (common bile 
duct obstruction or fistula), if intes-
tinal transit is increased (prolonged 
diarrhea), and if the absorptive func-
tion of the intestinal mucosa is im-
paired, as in sprue. In addition, pro-
longed treatment with certain antimi-
crobial drugs may result in a lack of 
Vitamin K-producing bacteria in the 
gut with consequent Vitamin K defi-
ciency. 
Accidental ingestion of anticoagu-
lants may occur, producing a marked 
elevation of the prothrombin time. This 
can be confirmed by examining all 
medications being taken by the patient. 
In recent months we have encountered 
two patients who received oral anti-
coagulants by accident. 1* In each in-
stance a severe hemorrhagic disorder 
resulted. A serum assay for an oral an-
ticoagulant should be obtained when 
a markedly prolonged prothrombin 
time is unexpectedly encountered. 
Drugs which have a similar but 
weaker effect than coumarin on clot-
ting factors include salicylates, phenyl-
butazone, quinidine^* and heparin. 
Several other drugs, although having 
no anticoagulant activity themselves, 
potentiate the action of the oral anti-
coagulants. Phenyramidol hydrochlor-
ide and clofibrate are such drugs.i'' 
In the presence of a naturally occur-
ring circulating anticoagulant the pro-
thrombin time is prolonged in almost 
every instance, sometimes to a marked 
degree. This is most commonly encoun-
tered in association with systemic lupus 
erythematosus, and can be recognized 
by failure to correct with added normal 
plasma (vide supra). Intravascular co-
agulation and fibrinolysis deplete the 
blood of prothrombin but the associ-
ated depression of Factors V and V I I I , 
and generally of platelets, removes con-
sideration of coumarin drug ingestion 
as a cause. 
Psycho-Sociological Considerations 
Relatively little is noted in the liter-
ature as to the psychodynamics of the 
patients with surreptitious ingestion of 
coumarin. These individuals usually 
appear to be intelligent and of average 
or above average socio-economic 
status. Previous experience with anti-
coagulants or some association with 
the medical profession is common in 
this group. Of the 36 cases (including 
our own) that appear in the literature, 
80% are female and 60% of all cases 
are registered nurses. Suspect indivi-
duals are those who have ready access 
to the drugs, such as pharmacists, 
nurses, doctors and orderlies. 
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None of these 36 patients under-
went extensive psychiatric evaluation. 
Attempts at psychiatric evaluations 
were made in two of our patients, but 
in both instances the patient viewed the 
psychiatrist as a detective, making it 
impossible to interview the patient in 
depth. Our fourth case, the student 
nurse, was of particular interest. This 
patient had focused the attention of her 
parents and doctors on symptoms from 
her urinary tract since childhood. One 
doctor referred to her symptoms as be-
ing "ninety per cent functional." The 
patient may well have felt that she was 
being ignored by her doctor and suc-
ceeded in startling him when she pre-
sented with hematuria. 
There can be considerable specula-
tion as to why an individual would sur-
reptitiously ingest a relatively danger-
ous drug. It would appear that the 
motive for bringing this bleeding dis-
order upon one's self would be to gain 
greater attention from family, friends, 
doctors, and the community. An under-
lying neurotic or psychotic process is 
likely. These patients could be consid-
ered to have a form of malingering. 
Our third patient was presumably at-
tempting suicide and, if so, was not 
truly malingering. 
The suggested approach is to con-
front the patient in a non-judgmental 
fashion. It is the physician's responsi-
bility to try to understand the patient's 
difficulty and to communicate to the 
patient his wish to help. The physician 
must inquire into the stresses that led 
the patient into this unusual behavior. 
Frequently, if not usually, the patient 
refuses the invitation to explore the sit-
uation further because of his resent-
ment and guilt. However, the ground-
work may be laid for the patient sub-
sequently to come to grips with his 
basic problems in a more constructive 
fashion. On the other hand, the patient 
may continue the surreptitious inges-
tion of anticoagulants or he may sub-
stitute another drug with possible 
greater hazard to health. 
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